This product implements the Short Contango Long Equity Strategy by investing 100% of its issue proceeds in the Invesco QQQ Trust. To actively capture variance risk premium, contango decay, and beta slippage, it maintains a combined short exposure of 25% - split equally between UVIX (12.5%) and BOIL (12.5%). This positioning aligns with the strategy's targeted allocation of 20% to 40% to high-contango asset classes, as set out in the Prospectus..